다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기
Tuberculosis and respiratory diseases : TRD = 결핵 및 호흡기 질환, v.60 no.4 = no.255, 2006년, pp.379 - 390
초록이 없습니다.
* AI 자동 식별 결과로 적합하지 않은 문장이 있을 수 있으니, 이용에 유의하시기 바랍니다.
Busse WW, Lemanske RF Jr. Asthma. N Engl J Med 2001;344:350-62
Haley KJ, Sunday ME, Wiggs BR, et al. Inflammatory cell distribution within and along asthmatic airways. Am J Respir Crit Care Med 1998;158:565-72
Kraft M, Djukanovic R, Wilson S, Holgate ST, Martin RJ. Alveolar tissue inflammation in asthma. Am J Respir Crit Care Med 1996;154:1505-10
Vignola AM, Chanez P, Campbell AM, et al. Airway inflammation in mild intermittent and in persistent asthma. Am J Respir Crit Care Med 1998;157: 403-409
Burrows B, Martinez FD, Halonen M, Barbee RA, Cline MG. Association of asthma with serum IgE levels and skin-test reactivity to allergens. N Engl J Med 1989;320:271-277
Noah TL, Becker S. Chemokines in nasal secretions of normal adults experimentally infected with respiratory syncytial virus. Clin Immunol 2000;97:43-49
Schwartz RS. A new element in the mechanism of asthma. N Engl J Med 2002;346:857-858
National Asthma Education and Prevention Program. Guidelines for the diagnosis and management of asthma. Bethesda, MD: National Heart, Lung, and Blood Institute, National Institutes of Health; 2004
Wills-Karp M, Luyimbazi J, Xu X, et al. Interleukin-13: central mediator of allergic asthma. Science 1998;282:2258-2261
Bacharier LB, Jabara H, Geha RS. Molecular mechanisms of immunoglobulin E regulation. Int Arch Allergy Immunol 1998;115:257-269
Siraganian RP. Biochemical events in basophil or mast cell activation and mediator release. In: Middleton E Jr, Reed CE, Ellis EF, Adkinson NF Jr, Yunginger JW, Busse WW, eds. Allergy: principles & practice. 5th ed. Vol. 1. St. Louis: Mosby？Year Book, 1998:204-27
Galli SJ. Complexity and redundancy in the pathogenesis of asthma: reassessing the roles of mast cells and T cells. J Exp Med 1997;186:343-347
Lane SJ, Lee TH. Mast cell effector mechanisms. J Allergy Clin Immunol 1996;98:S67-S72
Clark JM, Abraham WM, Fishman CE, et al. Tryptase inhibitors block allergen-induced airway and inflammatory responses in allergic sheep. Am J Respir Crit Care Med 1995;152:2076-2083
Brandenburg AH, van Beek R, Moll HA, Osterhaus ADME, Claas ECJ. G protein variation in respiratory syncytial virus group A does not correlate with clinical severity. J Clin Microbiol 2000;38:3849-3852.
Peters SP, Zangrilli JG, Fish JE. Late phase allergic reactions. In: Middleton E Jr, Reed CE, Ellis EF, Adkinson NF Jr, Yunginger JW, Busse WW, eds. Allergy: principles & practice. 5th ed. Vol. 1. St. Louis: Mosby？Year Book, 1998:342-55
Sanderson CJ. Interleukin-5, eosinophils, and disease. Blood 1992;79:3101-3109
Rothenberg ME. Eosinophilia. N Engl J Med 1998; 338:1592-1600
Bochner BS. Cellular adhesion and its antagonism. J Allergy Clin Immunol 1997;100:581-585
Wardlaw AJ. Molecular basis for selective eosinophil trafficking in asthma: a multistep paradigm. J Allergy Clin Immunol 1999;104:917-926
Nagata M, Sedgwick JB, Bates ME, Kita H, Busse WW. Eosinophil adhesion to vascular cell adhesion molecule-1 activates superoxide anion generation. J Immunol 1995;155:2194-2202
Yamamoto H, Sedgwick JB, Busse WW. Differential regulation of eosinophil adhesion and transmigration by pulmonary microvascular endothelial cells. J Immunol 1998;161:971-977
Hamid QA, Minshall EM. Molecular pathology of allergic disease. I. Lower airway disease. J Allergy Clin Immunol 2000;105:20-36
Nakamura Y, Ghaffar O, Olivenstein R, et al. Gene expression of the GATA-3 transcription factor is increased in atopic asthma. J Allergy Clin Immunol 1999;103:215-222
Robinson DS, Hamid Q, Ying S, et al. Predominant TH2-like bronchoalveolar T-lymphocyte population in atopic asthma. N Engl J Med 1992;326:298-304
Walker C, Bauer W, Braun RK, et al. Activated T cells and cytokines in bronchoalveolar lavages from patients with various lung diseases associated with eosinophilia. Am J Respir Crit Care Med 1994; 150:1038-1048
Aubus P, Cosso B, Godard P, et al. Decreased suppressor cell activity of alveolar macrophages in bronchial asthma. Am Rev Respir Dis 1984;130:875-8
Spiteri M, Knight RA, Jeremy JY, et al. Alveolar macrophage-induced suppression of T-cell hyperresponsiveness in bronchial asthma is reversed by allergen exposure. Eur Respir J 1994;7:1431-1438
Chung KF, Barnes PJ. Cytokines in asthma. Thorax 1999;54:825-857
Brewster CEP, Howarth PH, Djukanovic R, et al. Myofibroblasts and subepithelial fibrosis in bronchial asthma. Am J Respir Cell Mol Biol 1990;3:507-511
Hirst SJ, Barnes PJ, Twort CHL. Quantifying proliferation of cultured human and rabbit airway smooth muscle cells in response to serum and platelet-derived growth factor. Am J Respir Cell Mol Biol 1992;7:574-581
Cerutis DR, Nogami M, Anderson JL, et al. Lysophosphatidic acid and EGF stimulate mitogenesis in human airway smooth muscle cells. Am J Physiol 1997;273:L10-L15
Lynch KR, O'Neil GP, Liu Q, et al. Characterization of the human cysteinyl leukotriene CysLT1 receptor. Nature 1999;399:789-93
Yokomizo T, Izumi T, Chang K, et al. A G-protein- coupled receptor for leukotriene B4 that mediates chemotaxis. Nature 1997;387:620-4
Stafforini DM, Satoh K, Atkinson DL, et al. Platelet-activating factor acetylhydrolase deficiency : a missense mutation near the active site of an anti-inflammatory phospholipase. J Clin Invest 1996;97:2784-91
Stafforini DM, Numao T, Tsodikov A, et al. Deficiency of platelet-activating factor acetylhydrolase is a severity factor for asthma. J Clin Invest 1999; 103:989-97
Levitt RC, McLane MP, MacDonald D, et al. IL-9 pathway in asthma: new therapeutic targets for allergic inflammatory disorders. J. allergy Clin. Immunol. 1999; 103:s485-91.Holroyd KJ, Martinati LC, Trabetti E et al. Asthma and bronchial hyperresponsiveness linked to the XY long arm pseudoautosomal region. Genomics. 1998; 52:233-5
McLane MP, Haczku A, van de Rijn M et al. Interleukin-9 promotes allergen-induced eosinophilic inflammation and airway hyperresponsiveness in transgenic mice. Am J Respir Cell Mol Biol. 1998;19:713-20
Humbles AA, Lu B, Nilsson CA et al. A role for the C3a anaphylatoxin receptor in the effector phase of asthma. Nature 2000; 161:998-1001
Karp CL, Grupe A, Schadt E et al. Identification of complement factor 5 as a susceptibility locus for experimental allergic asthma. Nat. Immunol. 2000;1:221-6
Chalmers GW, Thomson L, Macleod KJ et al. Endothelin-1 levels in induced sputum samples from asthmatic and normal subjects. Thorax 1997; 100: 544-52
Redington AE, Springall DR, Ghatei MA et al. Airway endothelin levels in asthma: influence of endobronchial allergen challenge and maintenance corticosteroid therapy. Eur Respir J. 1997; 10: 1026-32
Redington AE, Springall DR, Meng QH et al. Immunoreactive endothelin in bronchial biopsy specimens: increased expression in asthma and modulation by corticosteroid therapy. J Allergy Clin Immunol. 1997; 100:544-52
Gustafsson LE, Leone AM, Persson MG, Wiklund NP, Moncada S. Endogenous nitric oxide is present in the exhaled air of rabbits, guinea pigs and humans. Biochem Biophys Res Commun. 1991; 181:852-7
Kharitonov SA, Yates D, Robbins RA et al. Increased nitric oxide in exhaled air of asthmatic patients. Lancet. 1994; 343:133-5
Massaro AF, Mehta S, Lilly CM et al. Elevated nitric oxide concentrations in isolated lower airway gas of asthmatic subjects. Am J Respir Crit Care Med. 1996; 153:1510-14
Jatakanon A, Lim S, Kharitonov SA, Chung KF, Barnes PJ. Correlation between exhaled nitric oxide, sputum eosinophils, and methacholine responsiveness in patients with mild asthma. Thorax. 1998; 53:91-5
Saleh D, Ernst P, Lim S, Barnes PJ, Giaid A. Increased formation of the potent oxidant peroxynitrite in the airways of asthmatic patients is associated with induction of nitric oxide synthase: effect of inhaled glucocorticoid. FASEB J. 1998;12: 929-37
Barnes PJ, Karin M. Nuclear factor-kappaB: a pivotal transcription factor in chronic inflammatory diseases. N Engl J Med. 1997; 336:1066-71
Hart LA, Krishnan VL, Adcock IM, Barnes PJ, Chung KF. Activation and localization of transcription factor, nuclear factor-kappaB, in asthma. Am J Respir Crit Care Med. 1998: 158 :1585-92
Selig W, Tocker J. Effect of interleukin-1 receptor antagonist on antigen-induced pulmonary responses in guinea pigs. Eur J Pharmacol. 1992; 213:331-6
Naseer T, Minshall EM, Leung DY et al. Expression of IL-12 and IL-13 mRNA in asthma and their modulation in response to steroid therapy. Am J Respir Crit Care Med. 1997; 155:845-51
Ho AS, Moore KW. Interleukin-10 and its receptor. Ther Immunol. 1994; 1:173-85
Wang P, Wu P, Siegel MI, Egan RW, Billah MM. Interleukin (IL)-10 inhibits nuclear factor kappa B (NF kappa B) activation in human monocytes. IL-10 and IL-4 suppress cytokine synthesis by different mechanisms. J Biol Chem. 1995; 270:9558-63
Borish L, Aarons A, Rumbyrt J et al. Interleukin-10 regulation in normal subjects and patients with asthma. J Allergy Clin Immunol. 1996; 97:1288-96
John M, Lim S, Seybold J et al. Inhaled corticosteroids increase interleukin-10 but reduce macrophage inflammatory protein-1alpha, granulocyte- macrophage colony-stimulating factor, and interferon-gamma release from alveolar macrophages in asthma. Am J Respir Crit Care Med.1998; 157:256-62
Spiteri MA, Knight RA, Jeremy JY et al. Alveolar macrophage-induced suppression of peripheral blood mononuclear cell responsiveness is reversed by in vitro allergen exposure in bronchial asthma. Eur Respir J. 1994; 7:1431-8
Medzhitov R, Janeway C Jr. Innate immunity. N Engl J Med 2000; 343:338-344
Medzhitov R, Janeway C Jr. Innate immunity. N Engl J Med 2000; 343:338-344
Eisenbarth SC, Classel S, Bottomly K. Understanding asthma pathogenesis: linking innate and adaptive immunity. Current opinion in Pediatrics 2004; 16:659-665
Cembrzynska-Nowak M, Szklarz E, Inglot AD, Teodorczyk-Injeyan JA. Elevate release of tumor necrosis factor- $\alpha$ and interferon- $\gamma$ by bron-choalveolar leukocytes from patients with bronchial asthma. Am Rev Respir Dis 1993; 147:291-295
Krug N, Madden J, Redington AE, Lackie P, Djukanovic R, Schauer U, Holgate ST, Frew AJ, Howarth PH. T-cell cytokine profile evaluated at the single cell level in BAL and blood in allergic asthma. Am J Respir Cell Mol Biol 1996; 14:319-326
Redecke V, Hacker H, Datta SK et al.: Cutting edge: activation of Toll-like receptor 2 induces a Th2 immune response and promotes experimental asthma. J Immunol 2004; 172:2739-2743
Walter MJ, Holtzman MJ. A centennial history of research on asthma pathogenesis. Am J Respir Cell Mol Biol 2005; 32:483-489
Copyright KISTI. All Rights Reserved.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.